Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases
Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues
Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyx™ Hyperplexed Immuno-Assay in Hodgkin Lymphoma
Using a Multiplexed Immunofluorescence Assay to Detect Immunosuppressive Cells and their Mechanisms in the Pancreatic Tumor Microenvironment
Using MultiOmyx™ to Analyze Correlations between Immunosuppressive Cells and Tumor-Infiltrating Lymphocytes in the Pancreatic Tumor Microenvironment
A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies
Clinicopathologic Characteristics and Novel Biomarkers of Aggressive B-Cell Lymphomas in the Nasopharynx
Association between microsatellite instability and BRAF, TP53, PTEN, and KRAS mutations in colorectal cancer